These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28414898)

  • 41. Advances in the evaluation and management of esophageal disease of systemic sclerosis.
    Carlson DA; Hinchcliff M; Pandolfino JE
    Curr Rheumatol Rep; 2015 Jan; 17(1):475. PubMed ID: 25475597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
    Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
    Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
    Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
    Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
    Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].
    Liang XY; Chen WN; Lan L; Wang Q; Lü YW; Lan Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):513-5. PubMed ID: 22943821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
    Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
    Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients with refractory reflux symptoms often do not have GERD.
    Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and therapy of atypical reflux symptoms when PPI therapy fails].
    Bajbouj M
    HNO; 2012 Mar; 60(3):193-9. PubMed ID: 22402899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update.
    Fock KM; Talley NJ; Fass R; Goh KL; Katelaris P; Hunt R; Hongo M; Ang TL; Holtmann G; Nandurkar S; Lin SR; Wong BC; Chan FK; Rani AA; Bak YT; Sollano J; Ho KY; Manatsathit S
    J Gastroenterol Hepatol; 2008 Jan; 23(1):8-22. PubMed ID: 18171339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
    Hong SK; Vaezi MF
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
    Blonski W; Vela MF; Castell DO
    J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical value of wireless pH-monitoring of gastro-esophageal reflux in children before and after proton pump inhibitors.
    Boström M; Thorsson O; Toth E; Agardh D
    BMC Gastroenterol; 2014 Dec; 14():3. PubMed ID: 25539736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined?
    Moore JM; Vaezi MF
    Curr Opin Gastroenterol; 2010 Jul; 26(4):389-94. PubMed ID: 20473157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reflux and acid peptic diseases in the elderly.
    Soumekh A; Schnoll-Sussman FH; Katz PO
    Clin Geriatr Med; 2014 Feb; 30(1):29-41. PubMed ID: 24267600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines on gastroesophageal reflux disease.
    Niaz SK; Quraishy MS; Taj MA; Abid S; Alam A; Nawaz AA; Ali Shah SH; Khan IM; Memon AR; Zuberi BF; Tayyab GN; Malik K; Mirza S; Abbas Z;
    J Pak Med Assoc; 2015 May; 65(5):532-41. PubMed ID: 26028389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation and treatment of GERD and upper GI complaints in athletes.
    Leggit JC
    Curr Sports Med Rep; 2011; 10(2):109-14. PubMed ID: 21623293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.